Rethink Recovery: A Qualitative Approach to Exploring Messaging for Medication-Assisted Recovery (MAR)

Abstract

Similar to national trends, in Illinois, fatal opioid overdoses have risen. Black men (35+) outrank all other racial subgroups for the highest rate of fatal opioid overdoses in the state. To address this, Prevention First and the Illinois Department of Human Services developed a public health education campaign to support increasing enrollment in recovery services, with a focus on Black men (35+). Self-reported Black participants with opioid use disorder (OUD) made up the analytic sample. Study goals were to understand lived experiences of the campaign audience; investigate knowledge, attitudes, and beliefs regarding OUD and treatment; explore perceived barriers and facilitators to treatment; and evaluate messaging that showcased medication-assisted recovery (MAR) as a viable tool for treatment and recovery. Interviews were recorded and transcribed for thematic analysis. Participants shared long and cyclical journeys of use and recovery. Participants had low levels of knowledge of available treatment options and struggled to imagine themselves in recovery because of the fear of cravings and withdrawal. Messaging that was realistic about the cyclical nature of recovery, showed the varying options for MAR, and addressed cravings and withdrawals were well received. These findings illustrate the importance of understanding an audience and involving them in campaign development to create messaging that promotes behavior change and sustained health. Through the Decision Blocks strategic framework, we discovered information gaps, barriers to treatment, and practical solutions to increase access to treatment for Black men with OUD that has been limited due to inequities caused by structural racism.

Keywords

Black males medication-assisted recovery opioid use disorder recovery

Get full access to this article

View all access options for this article.

References

Aldiabat

K. M.

Le Navenec

C. L.

(2018). Data saturation: The mysterious step in grounded theory methodology. The Qualitative Report, 23(1), 245–261. https://doi.org/10.46743/2160-3715/2018.2994

Bechtel

Ness

D. L.

(2010). If you build it, will they come? Designing truly patient-centered health care. Health Affairs, 29(5), 914–920. https://doi.org/10.1377/hlthaff.2010.0305

Berry

L. L.

Seiders

Wilder

S. S.

(2003). Innovations in access to care: A patient-centered approach. Annals of Internal Medicine, 139(7), 568–574. https://doi.org/10.7326/0003-4819-139-7-200310070-00009

Blanco

Wall

M. M.

Olfson

(2022). Expanding current approaches to solve the opioid crisis. JAMA Psychiatry, 79(1), 5–6. https://doi.org/10.1001/jamapsychiatry.2021.3136

Centers for Disease Control and Prevention. (2021a). Fentanyl facts. https://www.cdc.gov/stop-overdose/caring/fentanyl-facts.html

Centers for Disease Control and Prevention. (2021b). Understanding the epidemic. https://archive.cdc.gov/#/results?q=https://www.cdc.gov/drugoverdose/epidemic/index.html&start=0&rows=10&url=https://www.cdc.gov/drugoverdose/epidemic/index.html

Ciccarone

(2017). Fentanyl in the US heroin supply: A rapidly changing risk environment. International Journal of Drug Policy, 46, 107–111. https://doi.org/10.1016/j.drugpo.2017.06.010

Ciccarone

(2021). The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Addictive Disorders, 34(4), 344–350. https://doi.org/10.1097/yco.0000000000000717

Ciccarone

Ondocsin

Mars

S. G

. (2017). Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted “heroin.” International Journal of Drug Policy, 46, 146–155. https://doi.org/10.1016/j.drugpo.2017.06.004

10.

Earnshaw

Smith

Copenhaver

(2012). Drug addiction stigma in the context of methadone maintenance therapy: An investigation into understudied sources of stigma. International Journal of Mental Health and Addiction, 11(1), 110–122. https://doi.org/10.1007/s11469-012-9402-5

11.

Esrick

Kagan

R. G.

Carnevale

J. T.

Valenti

Rots

Dash

(2019). Can scare tactics and fear-based messages help deter substance misuse: A systematic review of recent (2005–2017) research. Drugs: Education, Prevention & Policy, 26(3), 209–218. https://doi.org/10.1080/09687637.2018.1424115

12.

Feelemyer

Des Jarlais

Arasteh

Abdul-Quader

A. S.

Hagan

(2013). Retention of participants in medication-assisted programs in low- and middle-income countries: An international systematic review. Addiction, 109(1), 20–32. https://doi.org/10.1111/add.12303

13.

Frkovich

Hedrick

Anakaraonye

A. R.

Bornkessel

Lefebvre

R. C.

(2022). Opioid-related public health communication campaigns: An environmental scan. American Journal of Health Promotion, 36(6), 913–919. https://doi.org/10.1177/08901171221082471

14.

Glaser

Strauss

(1999). Discovery of grounded theory: Strategies for qualitative research (1st ed.). Routledge. https://doi.org/10.4324/9780203793206

15.

Graffigna

Barello

Triberti

(Eds.). (2016). Patient engagement: A consumer-centered model to innovate healthcare (pp. 1–12). De Gruyter Open. https://doi.org/10.1515/9783110452440

16.

Hedegaard

Miniño

Spencer

M. R.

Warner

(2021, December 30). Drug overdose deaths in the United States, 1999–2020. Centers for Disease Control and Prevention. https://stacks.cdc.gov/view/cdc/112340

17.

Illinois Department of Public Health. (n.d.). Opioid data dashboard. https://idph.illinois.gov/OpioidDataDashboard/

18.

Illinois Department of Public Health. (2020a). Illinois opioid overdose epidemic during the COVID-19 pandemic. https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/il-opioid-overdoses-and-covid-pandemic-04012021.pdf

19.

Illinois Department of Public Health. (2020b, September). Opioid overdose semiannual report—September 2020. https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/semiannual-opioid-overdose-report9292020final.pdf

20.

Illinois Department of Public Health. (2021). Opioids: Illinois’ other epidemic. https://dph.illinois.gov/topics-services/opioids/idph-data-dashboard.html

21.

Illinois Department of Public Health. (2022). Statewide semiannual opioid report—May 2022. https://dph.illinois.gov/topics-services/opioids/idph-data-dashboard/statewide-semiannual-opioid-report-may-2022.html#Table1

22.

Karras

Warfield

S. C.

Stokes

C. M.

Bossarte

R. M.

(2018). Lessons from suicide prevention campaigns: Considerations for opioid messaging. American Journal of Preventive Medicine, 55(1), 125–128. https://doi.org/10.1016/j.amepre.2018.02.015

23.

Keselman

Logan

Smith

C. A.

Leroy

Zeng-Treitler

(2008). Developing informatics tools and strategies for consumer-centered health communication. Journal of the American Medical Informatics Association, 15(4), 473–483. https://doi.org/10.1097/QAI.0000000000002216

24.

Lefebvre

R. C.

Chandler

R. K.

Helme

D. W.

Kerner

Mann

Stein

M. D.

Reynolds

Slater

M. D.

Anakaraonye

A. R.

Beard

Burrus

Frkovich

Hedrick

Lewis

Rodgers

(2020). Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study. Drug and Alcohol Dependence, 217, 108338. https://doi.org/10.1016/j.drugalc-dep.2020.108338

25.

Mendoza

Rivera

A. S.

Hansen

H. B.

(2018). Re-racialization of addiction and the redistribution of blame in the white opioid epidemic. Medical Anthropology Quarterly, 33(2), 242–262. https://doi.org/10.1111/maq.12449

26.

Moore

M. D.

Ali

Burnich-Line

Gonzales

Stanton

M. V.

(2020). Stigma, opioids, and public health messaging: The need to disentangle behavior from identity. American Journal of Public Health, 110(6), 807–810. https://doi.org/10.2105/AJPH.2020.305628

27.

National Institute on Drug Abuse. (2018, September 11). Questions for identification of opioid use disorder based on DSM-5. https://nida.nih.gov/nidamed-medical-health-professionals/your-discipline/emergency-physicians-first-responders/questions-identification-opioid-use-disorder-based-dsm-5

28.

Olsen

Sharfstein

J. M.

(2014). Confronting the stigma of opioid use disorder—And its treatment. JAMA, 311(14), 1393–1394. https://doi.org/10.1001/jama.2014.2147

29.

Philadelphia Department of Behavioral Health and Intellectual Disability Services. (n.d.). Bupe works. https://dbhids.org/services/addiction-services/bupe-works/

30.

Rath

J. M.

Hair

E. C.

Barton

A. A.

Kreslake

J. M.

Geraci

Palmerini

Coderre

Vallone

D. M.

(2020). Early evidence of an opioid education campaign: A case study of Rhode Island. Journal of Public Health Management and Practice, 26(3), 252–258. https://doi.org/10.1097/phh.0000000000001154

31.

Reed

M. K.

Guth

Salcedo

V. J.

Hom

J. K.

Rising

K. L.

(2022). “You can’t go wrong being safe”: Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs. International Journal of Drug Policy, 103, 103643. https://doi.org/10.1016/j.drugpo.2022.103643

32.

Richter

Vuolo

Salmassi

M. S.

(2019). Stigma and addiction treatment. In Avery

J. D.

Avery

J. J.

(Eds.), The stigma of addiction (pp. 93–130). Springer.

33.

Somerville

N. J.

O’Donnell

Gladden

R. M.

Zibbell

J. E.

Green

T. C.

Younkin

Ruiz

Babakhanlou-Chase

Chan

Callis

B. P.

Kuramoto-Crawford

Nields

H. M.

Walley

A. Y.

(2017). Characteristics of fentanyl overdose—Massachusetts, 2014–2016. Morbidity and Mortality Weekly Report, 66(14), 382–386. https://doi.org/10.15585/mmwr.mm6614a2

34.

Stalgaitis

C. A.

Jordan

J. W.

Tate

Cruse

Bellon

Oruga

Hurley

(2023). There is hope and help: Reach and reception of a methamphetamine education campaign in Los Angeles County, California. Preventive Medicine Reports, 36, 102518. https://doi.org/10.1016/j.pmedr.2023.102518

35.

State of Illinois. (2022a). Governor Pritzker and Attorney General Raoul announce next steps in combatting opioid epidemic. https://www.illinois.gov/news/press-release.25240.html

36.

State of Illinois. (2022b). State of Illinois overdose action plan—March 2022. https://www.dhs.state.il.us/OneNetLibrary/27896/documents/By_Division/SUPR/State-of-Illinois-Overdose-Action-Plan-March-2022.pdf

37.

Urmanche

A. A.

Beharie

Harocopos

(2022). Fentanyl preference among people who use opioids in New York City. Drug and Alcohol Dependence, 237, 109519. https://doi.org/10.1016/j.drugalcdep.2022.109519

38.

van Olphen

Eliason

M. J.

Freudenberg

Barnes

. (2009). Nowhere to go: How stigma limits the options of female drug users after release from jail. Substance Abuse Treatment, Prevention, and Policy, 4, 10. https://doi.org/10.1186/1747-597x-4-10

39.

Wheeler

P. B.

Miller-Roenigk

Jester

Stevens-Watkins

(2024). Knowledge, experiences, and perceptions of medications for opioid use disorder among Black Kentuckians. Annals of Medicine, 56(1), 2322051. https://doi.org/10.1080/07853890.2024.2322051

40.

Winiker

A. K.

Tobin

K. E.

Gicquelais

R. E.

Owczarzak

Latkin

(2020). “When you’re getting high. . . you just don’t want to be around anybody.” A qualitative exploration of reasons for injecting alone: Perspectives from young people who inject drugs. Substance Use & Misuse, 55(13), 2079–2086. https://doi.org/10.1080/10826084.2020.1790008

41.

Yang

Mackert

(2021). The effectiveness of CDC’s Rx Awareness campaigns on reducing opioid stigma: Implications for health communication. Health Communication, 38(5), 925–934. https://doi.org/10.1080/10410236.2021.1982561